|
CSTF2T expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.82942591367919E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.66149999209142E-09 |
| Normal-vs-Stage2 |
5.30830002176685E-09 |
| Normal-vs-Stage3 |
1.64102065269844E-12 |
| Normal-vs-Stage4 |
1.68487446217114E-12 |
| Stage1-vs-Stage2 |
8.032100E-02 |
| Stage1-vs-Stage3 |
1.50976999999664E-05 |
| Stage1-vs-Stage4 |
1.033000E-04 |
| Stage2-vs-Stage3 |
1.695390E-01 |
| Stage2-vs-Stage4 |
1.946410E-01 |
| Stage3-vs-Stage4 |
9.967600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.66453567280223E-12 |
| Normal-vs-AfricanAmerican |
1.0301000052948E-08 |
| Normal-vs-Asian |
6.978700E-03 |
| Caucasian-vs-AfricanAmerican |
8.104800E-01 |
| Caucasian-vs-Asian |
8.953600E-01 |
| AfricanAmerican-vs-Asian |
9.757000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.97331040396875E-12 |
| Normal-vs-Female |
3.21659998636648E-09 |
| Male-vs-Female |
1.239890E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.29959999997753E-06 |
| Normal-vs-Age(41-60Yrs) |
5.64760460619596E-11 |
| Normal-vs-Age(61-80Yrs) |
4.20885548635397E-12 |
| Normal-vs-Age(81-100Yrs) |
2.77689999994557E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.998200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.400600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.118400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.800200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.511800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.242200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.474200E-01 |
| Normal-vs-Grade 2 |
7.16820003354712E-09 |
| Normal-vs-Grade 3 |
1.7883472480662E-12 |
| Normal-vs-Grade 4 |
6.66133814775094E-16 |
| Grade 1-vs-Grade 2 |
2.588400E-02 |
| Grade 1-vs-Grade 3 |
1.236300E-04 |
| Grade 1-vs-Grade 4 |
1.41529999997392E-06 |
| Grade 2-vs-Grade 3 |
8.0145000000087E-05 |
| Grade 2-vs-Grade 4 |
4.59879999969992E-07 |
| Grade 3-vs-Grade 4 |
2.340300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.97930000354208E-08 |
| Normal-vs-ccB subtype |
1.63224989080391E-12 |
| ccA subtype-vs-ccB subtype |
4.44570003033107E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.3936962695027E-11 |
| Normal-vs-N1 |
2.2113999999962E-05 |
| N0-vs-N1 |
3.067200E-01 |
|
|
